Fractyl Health, Inc. Share Price & Technical Analysis
GUTS · $0.91 (-1.09%)
Healthcare / Biotechnology
$0.91
-1.09%
Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. It develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. The company also develops Rejuva, a novel…
Price chart
Seasonality
May has 2 positive and 1 negative years (last 3 years shown)
50% return in May, 22% avg return in past 3 year May month.
-7% return in 2026, -36% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -77% | 0% | 0% | 20% | 50% | – | – | – | – | – | – | – | -7% |
| 25 | -14% | -11% | -25% | 0% | 46% | -16% | 13% | -44% | 60% | -25% | 33% | 47% | 63% |
| 24 | – | -35% | -20% | 17% | -1% | -37% | -27% | 6% | -26% | 12% | -7% | -16% | -135% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Downtrend · Strong
Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. It develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. The company also develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$119.53M
P/E ratio
—
52W high
$3.03
52W low
$0.38
Volume
18,88,321
Beta
2.11
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Fractyl Health, Inc. share price today?
- Fractyl Health, Inc. (GUTS) last traded around $0.91 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does GUTS have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for GUTS. Download the app for real-time alerts.
- How can I analyze Fractyl Health, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.